Surgical Innovations Group plc (SUN) - Total Liabilities
Based on the latest financial reports, Surgical Innovations Group plc (SUN) has total liabilities worth GBX2.94 Million GBX (≈ $357.47 USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore SUN cash flow metrics to assess how effectively this company generates cash.
Surgical Innovations Group plc - Total Liabilities Trend (1989–2024)
This chart illustrates how Surgical Innovations Group plc's total liabilities have evolved over time, based on quarterly financial data. See Surgical Innovations Group plc shareholders equity for net asset value and shareholders' equity analysis.
Surgical Innovations Group plc Competitors by Total Liabilities
The table below lists competitors of Surgical Innovations Group plc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Brighton Pier Group PLC
LSE:PIER
|
UK | GBX42.22 Million |
|
Feedback PLC
LSE:FDBK
|
UK | GBX589.02K |
|
Allianz Malaysia Bhd
KLSE:1163PA
|
Malaysia | RM23.66 Billion |
|
AIQ Ltd
LSE:AIQ
|
UK | GBX1.04 Million |
|
Vox Valor Capital Ltd.
LSE:VOX
|
UK | GBX4.81 Million |
|
Jereissati Participações S.A.
SA:IGTI11
|
Brazil | R$4.79 Billion |
|
Bumrungrad Hospital Public Company Limited
F:BZ7A
|
Germany | €5.29 Billion |
|
Georgina Energy PLC
LSE:GEX
|
UK | GBX3.13 Million |
Liability Composition Analysis (1989–2024)
This chart breaks down Surgical Innovations Group plc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see SUN stock market capitalisation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.11 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.34 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.26 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Surgical Innovations Group plc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Surgical Innovations Group plc (1989–2024)
The table below shows the annual total liabilities of Surgical Innovations Group plc from 1989 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | GBX3.70 Million ≈ $449.82 |
-3.62% |
| 2023-12-31 | GBX3.84 Million ≈ $466.73 |
-17.18% |
| 2022-12-31 | GBX4.63 Million ≈ $563.58 |
-8.35% |
| 2021-12-31 | GBX5.05 Million ≈ $614.93 |
-3.79% |
| 2020-12-31 | GBX5.25 Million ≈ $639.14 |
+27.53% |
| 2019-12-31 | GBX4.12 Million ≈ $501.16 |
-6.54% |
| 2018-12-31 | GBX4.41 Million ≈ $536.20 |
-8.63% |
| 2017-12-31 | GBX4.82 Million ≈ $586.82 |
+384.24% |
| 2016-12-31 | GBX996.00K ≈ $121.18 |
-74.06% |
| 2015-12-31 | GBX3.84 Million ≈ $467.22 |
-25.51% |
| 2014-12-31 | GBX5.16 Million ≈ $627.21 |
-15.93% |
| 2013-12-31 | GBX6.13 Million ≈ $746.09 |
+30.63% |
| 2012-12-31 | GBX4.69 Million ≈ $571.12 |
-25.88% |
| 2011-12-31 | GBX6.33 Million ≈ $770.54 |
+114.53% |
| 2010-12-31 | GBX2.95 Million ≈ $359.17 |
+1.86% |
| 2009-12-31 | GBX2.90 Million ≈ $352.60 |
-5.51% |
| 2008-12-31 | GBX3.07 Million ≈ $373.17 |
+56.24% |
| 2007-12-31 | GBX1.96 Million ≈ $238.84 |
+74.80% |
| 2006-12-31 | GBX1.12 Million ≈ $136.64 |
+6.34% |
| 2005-12-31 | GBX1.06 Million ≈ $128.48 |
-16.06% |
| 2004-12-31 | GBX1.26 Million ≈ $153.06 |
-14.01% |
| 2003-12-31 | GBX1.46 Million ≈ $178.00 |
+38.02% |
| 2002-12-31 | GBX1.06 Million ≈ $128.97 |
+54.74% |
| 2001-12-31 | GBX685.00K ≈ $83.34 |
+10.66% |
| 2000-12-31 | GBX619.00K ≈ $75.31 |
-75.89% |
| 1999-12-31 | GBX2.57 Million ≈ $312.33 |
+5.68% |
| 1998-12-31 | GBX2.43 Million ≈ $295.54 |
+1185.19% |
| 1997-12-31 | GBX189.00K ≈ $23.00 |
-63.09% |
| 1996-08-31 | GBX512.00K ≈ $62.30 |
-60.22% |
| 1995-08-31 | GBX1.29 Million ≈ $156.59 |
+6.36% |
| 1994-08-31 | GBX1.21 Million ≈ $147.22 |
-8.33% |
| 1993-08-31 | GBX1.32 Million ≈ $160.61 |
-10.45% |
| 1992-08-31 | GBX1.47 Million ≈ $179.34 |
+7.67% |
| 1991-08-31 | GBX1.37 Million ≈ $166.57 |
+32.40% |
| 1990-08-31 | GBX1.03 Million ≈ $125.81 |
+0.19% |
| 1989-08-31 | GBX1.03 Million ≈ $125.56 |
-- |
About Surgical Innovations Group plc
Surgical Innovations Group plc, together with its subsidiaries, engages in the design, manufacture, and export of medical products for use in laparoscopic and robotic minimally invasive surgery in the United Kingdom, Europe, the Asia Pacific, the United States, and internationally. The company operates through three segments: SI Brand, Original Equipment Manufacturer (OEM), and Distribution. It o… Read more